BioCentury
ARTICLE | Clinical News

BC-819 regulatory update

September 28, 2015 7:00 AM UTC

FDA granted Fast Track designation to BioCancell’s BC-819 to treat bladder cancer. Next half, the company plans to start 2 Phase III trials of the plasmid encoding diphtheria toxin to treat non-muscle...